Safety and Efficacy of J147 in Acute Ischemic Stroke
Clinical trial NCT07430917 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07430917
- Sponsor
- Abrexa Pharmaceuticals, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2028-03-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.